Combating Illicit Xylazine Act

Sponsored byRep. Panetta, Jimmy [D-CA-19]CA· Introduced 12 février 2025

Open on Congress.gov

114

Cosponsors

Actions

Amendments

Committees

—

Since introduced

Introduced

Committee

Passed Chamber

Passed Both

Enacted

Step 1 of 0

Latest action

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.

16 septembre 2026·5 days ago

Summary

Introduced in House · Updated 27 août 2026

Combating Illicit Xylazine Act

This bill regulates xylazine under the Controlled Substances Act (CSA).

Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.

This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.

Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.

The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs.

The bill also exempts xylazine manufacturers from the CSA's physical security requirements.

Finally, the bill requires the DEA, in coordination with the Food and Drug Administration, to report on (1) the prevalence and impact of illicit xylazine use in the United States, and (2) updated information on the prevalence and proliferation of xylazine trafficking and misuse in the United States.

Timeline

22 actions

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.
16 septembre 2026 · Calendars
DEBATE - The House proceeded with forty minutes of debate on H.R. 1266.
15 septembre 2026 · Floor
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
15 septembre 2026 · Floor
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
15 septembre 2026 · Floor
Considered under suspension of the rules.
15 septembre 2026 · Floor
Motion to reconsider laid on the table Agreed to without objection.
15 septembre 2026 · Floor
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
15 septembre 2026 · Floor
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
15 septembre 2026 · Floor
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
14 septembre 2026 · Committee
Committee on the Judiciary discharged.
14 septembre 2026 · Discharge
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
14 septembre 2026 · Committee
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
14 septembre 2026 · Committee
Placed on the Union Calendar, Calendar No. 715.
14 septembre 2026 · Calendars
Committee on the Judiciary discharged.
14 septembre 2026 · Committee
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
14 septembre 2026 · Committee
Committee on the Judiciary discharged.
14 septembre 2026 · Committee
Placed on the Union Calendar, Calendar No. 715.
14 septembre 2026 · Calendars
Committee on the Judiciary discharged.
14 septembre 2026 · Discharge
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
14 septembre 2026 · Committee
Committee Consideration and Mark-up Session Held
21 juillet 2026 · Committee

2 earlier actionsView all on Congress.gov

Sponsorship

114 cosponsors

Sponsor

Rep. Panetta, Jimmy [D-CA-19]CA

Cosponsors

Democrat2346%
Republican2754%

Democrat:Rep. Horsford, Steven [D-NV-4]NV
Democrat:Rep. Goodlander, Maggie [D-NH-2]NH
Democrat:Rep. Titus, Dina [D-NV-1]NV
Democrat:Rep. Peters, Scott H. [D-CA-50]CA
Republican:Rep. De La Cruz, Monica [R-TX-15]TX
Republican:Rep. Goldman, Craig A. [R-TX-12]TX
Republican:Rep. Joyce, John [R-PA-13]PA
Republican:Rep. Biggs, Sheri [R-SC-3]SC
Republican:Rep. Mackenzie, Ryan [R-PA-7]PA
Democrat:Rep. Gillen, Laura [D-NY-4]NY
Republican:Rep. Edwards, Chuck [R-NC-11]NC
Democrat:Rep. Gottheimer, Josh [D-NJ-5]NJ
Republican:Rep. Moore, Tim [R-NC-14]NC
Democrat:Rep. Trahan, Lori [D-MA-3]MA
Republican:Rep. Langworthy, Nicholas A. [R-NY-23]NY
Republican:Rep. Alford, Mark [R-MO-4]MO
Democrat:Rep. Foushee, Valerie P. [D-NC-4]NC
Republican:Rep. Bergman, Jack [R-MI-1]MI
Democrat:Rep. Ivey, Glenn [D-MD-4]MD
Republican:Rep. DesJarlais, Scott [R-TN-4]TN
Democrat:Rep. Perez, Marie Gluesenkamp [D-WA-3]WA
Democrat:Rep. Vasquez, Gabe [D-NM-2]NM
Democrat:Rep. Garamendi, John [D-CA-8]CA
Democrat:Rep. Riley, Josh [D-NY-19]NY
Democrat:Rep. Lofgren, Zoe [D-CA-18]CA
Republican:Rep. Evans, Gabe [R-CO-8]CO
Democrat:Rep. Schrier, Kim [D-WA-8]WA
Republican:Rep. Schmidt, Derek [R-KS-2]KS
Democrat:Rep. Kennedy, Timothy M. [D-NY-26]NY
Republican:Rep. Fischbach, Michelle [R-MN-7]MN
Republican:Rep. Jackson, Ronny [R-TX-13]TX
Republican:Rep. Lucas, Frank D. [R-OK-3]OK
Democrat:Rep. McBride, Sarah [D-DE-At Large]DE
Democrat:Rep. Budzinski, Nikki [D-IL-13]IL
Republican:Rep. Van Orden, Derrick [R-WI-3]WI
Democrat:Rep. McDonald Rivet, Kristen [D-MI-8]MI
Republican:Rep. Nunn, Zachary [R-IA-3]IA
Republican:Rep. Nehls, Troy E. [R-TX-22]TX
Republican:Rep. Weber, Randy K. Sr. [R-TX-14]TX
Republican:Rep. Van Duyne, Beth [R-TX-24]TX
Republican:Rep. Kim, Young [R-CA-40]CA
Democrat:Rep. Scholten, Hillary J. [D-MI-3]MI
Republican:Rep. Letlow, Julia [R-LA-5]LA
Republican:Rep. Baird, James R. [R-IN-4]IN
Republican:Rep. Carter, Earl L. "Buddy" [R-GA-1]GA
Democrat:Rep. Min, Dave [D-CA-47]CA
Republican:Rep. Bentz, Cliff [R-OR-2]OR
Republican:Rep. Grothman, Glenn [R-WI-6]WI
Democrat:Rep. Gray, Adam [D-CA-13]CA
Democrat:Rep. Tokuda, Jill N. [D-HI-2]HI

View all on Congress.gov

Classification

Policy area

Crime and Law Enforcement

Legislative subjects

Congressional oversightConsumer affairsCriminal procedure and sentencingDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesLicensing and registrationsManufacturingU.S. Sentencing CommissionVeterinary medicine and animal diseases

Committees

Energy and Commerce Committee
House · Standing
- Referred To12 Feb 2025
- Markup By20 Jul 2026
- Markup By21 Jul 2026
- Health Subcommittee
  - Referred to12 Feb 2025
  - Markup by25 Jun 2026
  - Reported by25 Jun 2026
Judiciary Committee
House · Standing
- Referred To12 Feb 2025

Track Combating Illicit Xylazine Act as it moves through Congress